Matrix Metalloproteinase 9 Point-of-Care Immunoassay Result Predicts Response to Topical Cyclosporine Treatment in Dry Eye Disease

PURPOSE: We evaluate a matrix metalloproteinase-9 (MMP-9) point-of-care immunoassay (InflammaDry) as a prognostic tool for topical cyclosporine treatment. METHODS: A total of 20 healthy subjects and 40 patients meeting >3 dry eye disease (DED) criteria (ocular surface disease index [OSDI] score ≥...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jae Yong, Kim, Bum Gi, Kim, Jae Suk, Hwang, Je Hyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205558/
https://www.ncbi.nlm.nih.gov/pubmed/30386683
http://dx.doi.org/10.1167/tvst.7.5.31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205558/
https://www.ncbi.nlm.nih.gov/pubmed/30386683
http://dx.doi.org/10.1167/tvst.7.5.31

Ejemplares similares